No Data
No Data
Express News | Aadi Bioscience Inc : Jefferies Raises Target Price to $2 From $1.5
Aadi Biosciences | 10-Q: Q3 2024 Earnings Report
Aadi Biosciences | 8-K: Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update
Express News | Aadi Bioscience Remains Actively Engaged In A Comprehensive Strategic Review To Maximize Shareholder Value
Express News | Aadi Bioscience Is Completing Wind-down Of PRECISION1 Trial Of Nab-sirolimus In Patients With Solid Tumors Harboring TSC1 Or TSC2 Inactivating Alterations
Aadi Bioscience GAAP EPS of -$0.46 In-line, Revenue of $7.21M Beats by $0.61M
Unlock the Full List